Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07205068 · ClinicalTrials.gov registry record · NA

Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure

A NA study of Aortic Stenosis, sponsored by University of Tennessee Graduate School of Medicine.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07205068 is a NA study of Aortic Stenosis that is actively recruiting participants, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 100 participants, below the 1,358-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07205068, a NA study of Aortic Stenosis, is actively recruiting participants, sponsored by University of Tennessee Graduate School of Medicine.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to observe reduced access site complications in patients with heavily calcified common femoral arteries requiring Transcatheter Aortic Valve Replacement (TAVR)

Conditions Studied

Interventions

  • DEVICE Shockwave M5 IVL Catheter
  • PROCEDURE Modified Seldinger Technique

Study Locations (1)

Tennessee

  • University of Tennessee Medical Center - Knoxville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-10-04
Est. Completion 2026-11-04
Phase NA

What the Registry Record Tells You About NCT07205068

The ClinicalTrials.gov registry entry for NCT07205068 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,358-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (93% lower). The listed sponsor is University of Tennessee Graduate School of Medicine, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aortic Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Shockwave M5 IVL Catheter is the first listed.

NCT07205068 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT07205068 about?

NCT07205068 is a clinical study titled "Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure". The primary purpose of this study is to observe reduced access site complications in patients with heavily calcified common femoral arteries requiring Transcatheter Aortic Valve Replacement (TAVR)

What is the current status of trial NCT07205068?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-04. Estimated completion is 2026-11-04.

What conditions does trial NCT07205068 study?

This clinical trial studies the following conditions: Aortic Stenosis.

What interventions are being tested in trial NCT07205068?

The interventions under investigation include: Shockwave M5 IVL Catheter (DEVICE), Modified Seldinger Technique (PROCEDURE).

Who is sponsoring clinical trial NCT07205068?

This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07205068 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.